Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

23andMe, Anne Wojcicki

CNN on MSN · 2d
Anne Wojcicki’s nonprofit wins bid to acquire genetic testing company 23andMe
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Fox Business on MSN · 10h
23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company
Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.
Entrepreneur on MSN · 14h
23andMe's Former CEO Anne Wojcicki Just Regained Control of the Company She Cofounded. Here's How.
TTAM replaces biotech company Regeneron as 23andMe's buyer. Last month, Regeneron won the bidding during the bankruptcy auction to purchase 23andMe for $256 million. Wojcicki reop
ConsumerAffairs
14h
23andMe founder saves company with last-minute $305 million bid
DNA data saved: 23andMe co-founder Anne Wojcicki has bid $305 million through a nonprofit to acquire her bankrupt company, ...
8hon MSN
Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
3h
California objects to 23andMe sale to former CEO, says it would skirt state privacy law
California says the sale of 23andMe to a nonprofit formed by the company's former CEO would skirt a state law specifically ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy